PIKFYVE and cancer: Autophagy-dependent cancer cells are much more sensitive than non-malignant cells to WX8 and related PIKFYVE inhibitors when quantified by a loss of cellular ATP (~2000X), cell proliferation (~50X), cell permeability (~65X) or genomic DNA (~75X) [8–10] (Figure 1).